Neuromodulation to Facilitate the Effect of Ketamine
CompletedNCT01816958
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
application of external neuromodulation along with ketamine infusion.
Study details
- Official title
- Treatment of Thalamocortical Dysrhythmia Using External Neuromodulation to Facilitate the Therapeutic Effect of Ketamine.
- Conditions
- Depression
- Chronic Pain
- Substance Abuse
- Interventions
- Other: co-administration of TMS and infused ketamine
- Sponsor
- The Neuroscience Center, LLC
- Start date
- 2011-01
- Primary completion
- 2012-11
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * chronically ill, * treatment-resistant Exclusion Criteria: * active psychosis
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01816958